Medicines Discovery Catapult (MDC) and Crown Bioscience have formed a strategic global collaboration to deliver an integrated translational biology platform for innovators developing radiopharmaceuticals. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250911458780/en/RPTs: Pre-clinical Drug Discovery Pipeline Radiopharmaceuticals are a growing class of medicines that contain radioactive forms of chemical elements (called radioisotop...